EN
Home/Answers/Telling people you take a GLP-1
ALLAll countries Food and daily life

Should I tell people I am on tirzepatide or semaglutide?

What we checked16 sources, each one opened and linked to the sentence it supportsLast checked Nov 9, 2026 · Next review due Nov 9, 2027 · How we write
The short answer

Yes, tell your healthcare team about tirzepatide (Mounjaro, Zepbound) or semaglutide (Ozempic, Wegovy). The labels we read don't ask you to tell friends or colleagues. The US Zepbound and Wegovy labels say to inform providers before planned surgery or procedures, because these medicines slow stomach emptying. In 2026 experiments, GLP-1 weight loss was judged more harshly than diet and exercise.

Who should you always tell about taking a GLP-1?

Tell anyone treating you that you take one, because tirzepatide and semaglutide slow stomach emptying, which can matter during anaesthesia or deep sedation.12

The US Zepbound and Wegovy labels describe rare reports of stomach contents reaching the lungs during anaesthesia or deep sedation, even after fasting. Both instruct patients to tell healthcare providers before any planned surgery or procedure.12 The EU Mounjaro leaflet asks people due for surgery under anaesthesia to tell their doctor.3 A 2025 UK consensus statement says the risk, and ways to lower it, should be discussed with the patient.4

The US Zepbound label says a prescriber reducing insulin or a sulfonylurea may lower the risk of low blood sugar. It also asks patients to say if they are pregnant or plan to be.1

Tirzepatide may make contraceptive pills less effective, says the same label. It advises switching to a non-oral method, or adding a barrier method, for 4 weeks after starting and after each dose increase.1 For semaglutide, the EU Wegovy product information found no clinically relevant change with contraceptive pills.5

The label sections we read do not mention telling friends or employers.123

Is it worth telling one person close to you?

If you also take insulin or a sulfonylurea, someone near you should know how to treat severe low blood sugar, the NHS advises.6

The NHS also advises carrying medical ID if you take medicine for diabetes.6 A US Zepbound label trial studied people with type 2 diabetes. Low blood sugar affected 10.3% on a sulfonylurea and 2.1% of those not on one.1

We found no study of whether telling someone makes treatment safer.

Will people judge you for taking a GLP-1?

Some people may, because 2026 experiments found fictional people who lost weight on a GLP-1 were judged more harshly than people who dieted and exercised.78

One experiment with 607 people rated a GLP-1 user below someone who dieted and exercised, or who had not lost weight.7 Another, with 402 US women, linked higher stigma to seeing a GLP-1 as a shortcut.8 Both rated fictional people, so neither shows how your own friends will react.78

In an interview study of 34 users, many checked other people's attitudes before telling them. Some kept it secret after hearing friends or relatives criticise GLP-1 users.9 A US study interviewed 30 adults, mostly with type 2 diabetes. Participants felt weight-loss use was viewed more negatively than diabetes use.10

A 2020 international consensus says weight stigma rests on a typically unproven assumption about self-discipline. It links stigma with depressive symptoms and anxiety.11 If comments leave you with thoughts of harming yourself, treat that as an emergency and use the red box below.15

How can you answer if someone asks?

We found no trial testing what to say, but one interview study warns that some common explanations can sustain stigma about GLP-1 use.12

In that study, people often stressed how hard they worked. Some sorted users into those taking it the “right way” and the “wrong way”.9 In the US study of 30 adults, some stressed their diabetes to avoid judgement.10 The 34-user study's authors say such strategies can help manage stigma, yet may keep stigmatising talk going.12

The CDC's summary of the US HIPAA Privacy Rule lists health plans, healthcare providers and their business associates. A friend or colleague is not on that list, so it does not bind them.13

What do people on GLP-1 medicines report about telling others?

From public patient forums: 425 Reddit threads in r/Zepbound, r/mounjarouk, r/Mounjaro, r/WegovyWeightLoss, r/Semaglutide and r/Ozempic, read across posts from October 2025 to October 2026. Personal reports, not medical evidence. The largest batch came mostly from threads already about stigma or disclosure, so these shares do not show how common a view is among all users.

What people describe

  • Matches the interview study Many tell only a partner, a few close people, or nobody. An interview study also found some users keeping it secret.9
  • Matches the study Many describe judgement, or fear of it, including being seen as taking the easy way out.8
  • Not studied Reactions to telling are mixed. Several describe curious, supportive or indifferent responses, while several others say it backfired through gossip, food monitoring or dismissed effort. We found no study comparing telling with not telling.
  • Not studied Several say they were told they look too thin or ill, often while overweight or at a stable, healthy weight. In a few of these, replies thought the concern might be valid. We found no study of this.

Advice people share

  • Not studied Many say medical information is private. Many give a true but partial answer, such as eating less. Several keep a short line ready, and a few dispute crediting only diet and exercise. We found no trial of these replies.
  • Partly matches the label Several make sure a close person or written record covers emergencies, side effects or anaesthesia. The US Zepbound label covers only the anaesthesia part: it tells patients to inform providers before planned surgery or procedures.1
  • Label says otherwise A few posts describe storing medicine outside its limits, or not telling clinicians they take it. The US Zepbound label sets storage limits for each pack type and tells patients to inform providers before planned surgery or procedures.1
  • Label says otherwise Several posts mention changing doses outside the prescription or using compounded or unapproved products. The US Zepbound label gives a once-weekly schedule with set dose steps.1 The WHO warns of falsified semaglutide and advises using medicines as prescribed and avoiding unverified sources.14

In your country

Telling your healthcare team applies everywhere, but label advice on tirzepatide and the contraceptive pill differs in the EU.13

Australia

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.

Label: The answer above applies.

Emergency number: 000

Life on a GLP-1 in Australia

Canada

Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.

Label: The answer above applies.

Emergency number: 911

Life on a GLP-1 in Canada

France

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).

Label: The EU Mounjaro product information calls the fall in contraceptive pill levels after one tirzepatide dose not clinically relevant, with no pill dose change required. It does not carry the US label's advice to switch or add a barrier method.13

Emergency number: 15 or 112

Life on a GLP-1 in France

Germany

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.

Label: The EU Mounjaro product information calls the fall in contraceptive pill levels after one tirzepatide dose not clinically relevant, with no pill dose change required. It does not carry the US label's advice to switch or add a barrier method.13

Emergency number: 112

Life on a GLP-1 in Germany

India

Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).

Label: We could not open an Indian label for this page, so it relies on the US and EU labels cited above.

Emergency number: 112

Life on a GLP-1 in India

Saudi Arabia

Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.

Label: We could not open a Saudi label for this page, so it relies on the US and EU labels cited above.

Emergency number: 997 or 911

Life on a GLP-1 in Saudi Arabia

United Arab Emirates

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.

Label: We could not open a UAE label for this page, so it relies on the US and EU labels cited above.

Emergency number: 998 for an ambulance, or 999

Life on a GLP-1 in the UAE

United Kingdom

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.

Label: The answer above applies.

Emergency number: 999

Life on a GLP-1 in the UK

United States

Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).

Label: The answer above applies.

Emergency number: 911

Life on a GLP-1 in the US

Get help now: call your local emergency number Get emergency help for trouble breathing, swelling of the face, throat or tongue, fainting, chest or upper abdominal pain or pressure lasting 2 minutes or more, any sudden or severe pain, or suicidal feelings.1516 Emergency numbers: 911 in the US and Canada, 999 in the UK, 998 or 999 in the UAE, 000 in Australia, 112 in India and Germany, 15 or 112 in France, 997 or 911 in Saudi Arabia.

Contact your prescriber or a doctor right away if you have nausea, vomiting or diarrhoea that does not go away, as the US Zepbound Medication Guide says. It says the same about gallbladder symptoms such as upper stomach pain, fever, yellow skin or eyes, or clay-coloured stools.1

Read the full picture

Related questions

Did this answer your question?

Sources

  1. US Zepbound (tirzepatide) prescribing information and Medication Guide, Eli Lilly: uspl.lilly.com/zepbound
  2. US Wegovy (semaglutide) prescribing information, Novo Nordisk, on DailyMed: dailymed.nlm.nih.gov
  3. EU Mounjaro (tirzepatide) product information and package leaflet, European Medicines Agency: ema.europa.eu
  4. El-Boghdadly K, et al. Elective peri-operative management of adults taking GLP-1 receptor agonists, GIP agonists and SGLT-2 inhibitors: a multidisciplinary consensus statement. Anaesthesia 2025;80(4):412-424: pmc.ncbi.nlm.nih.gov
  5. EU Wegovy (semaglutide) product information, European Medicines Agency: ema.europa.eu
  6. NHS. Low blood sugar (hypoglycaemia): nhs.uk
  7. Standen EC, Phelan SM, Tomiyama AJ. An experimental investigation of the stigmatization of weight loss and regain from GLP-1 receptor agonist use and cessation. International Journal of Obesity 2026. Abstract record on Europe PMC: ebi.ac.uk/europepmc
  8. Georgetown Lombardi Comprehensive Cancer Center news release on Post S, Stock ML, Persky S, Stigma and Health, 2026: lombardi.georgetown.edu
  9. Newsweek report on Lazenby B, et al., Health Communication, 2026: newsweek.com
  10. de Vere Hunt I, et al. Patient Experiences With GLP-1 Receptor Agonists. JAMA Network Open 2026;9(6):e2616951: jamanetwork.com
  11. Rubino F, et al. Joint international consensus statement for ending stigma of obesity. Nature Medicine 2020: doi.org/10.1038/s41591-020-0803-x
  12. Lazenby B, et al. “They Call Us Cheaters”: Exploring Stigma Management Communication Strategies During GLP-1 Medication Use. Health Communication 2026. Abstract record on Europe PMC: ebi.ac.uk/europepmc
  13. US Centers for Disease Control and Prevention. Health Insurance Portability and Accountability Act of 1996 (HIPAA): cdc.gov
  14. World Health Organization. WHO issues warning on falsified medicines used for diabetes treatment and weight loss, 20 June 2024: who.int
  15. American College of Emergency Physicians. Know When to Go: emergencyphysicians.org
  16. American College of Emergency Physicians. Allergies and Anaphylaxis: emergencyphysicians.org

Last checked Nov 9, 2026 · Next review due Nov 9, 2027 · Report an error

How this answer was made. Written by the GLP Guidebook team from the sources above, all checked on Nov 9, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write